GlassScriptPhysician profile
Vincent Michael Padula
NPI 1558397083
$3,144.23
in general payments reported to CMS, 2019-2025
29 companies · $95.11 in 2025
The $95.11 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,133 · 2020: $201 · 2021: $25.93 · 2022: $79.84 · 2023: $214 · 2024: $396 · 2025: $95.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,483.76 | 2019-2020 | |
| Nevro Corp. | $314.54 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $200.02 | 2019-2024 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $195.65 | 2019-2025 | Relistor |
| Si-Bone, INC. | $124.83 | 2022-2024 | |
| Scilex Pharmaceuticals INC. | $105.39 | 2019-2020 | |
| Daiichi Sankyo INC. | $92.44 | 2019 | |
| Bioventus LLC | $82.95 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $57.56 | 2023-2024 | Xeomin |
| Mdd US Operations, LLC | $48.44 | 2019 | |
| Integrity Implants INC. Dba Accelus | $41.09 | 2023 | |
| Kaleo, INC. | $40.58 | 2019 | |
| Davol INC. | $34.92 | 2024 | Arista Ah Flexitip |
| Abbott Laboratories | $30.26 | 2020-2022 | |
| Depuy Synthes Sales INC. | $29.99 | 2020-2023 | Peak, Monovisc, Orthovisc |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $26.91 | 2019 | |
| Biodelivery Sciences International, INC. | $26.49 | 2019 | |
| Zimmer Biomet Holdings, INC. | $25.93 | 2021 | |
| Globus Medical, INC. | $25.90 | 2025 | Senza |
| Horizon Therapeutics Plc | $24.22 | 2019-2020 | |
| Medtronic, INC. | $19.35 | 2024 | Intellis Adaptivestim |
| Forte Bio-Pharma LLC | $16.67 | 2023 | Prolate, Nalocet |
| Vertex Pharmaceuticals Incorporated | $14.92 | 2025 | |
| Ferring Pharmaceuticals INC. | $14.49 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.35 | 2022 | |
| Ibsa Pharma INC. | $13.87 | 2023 | Tirosint, Licart |
| Pacira Therapeutics, INC. | $13.71 | 2020 | |
| Solventum Corporation | $13.63 | 2024 | Prevena |
| Assertio Therapeutics, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Padula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.